Literature Request | Mailing List | E-Mail New Product Newsletter | Lab Protocols and Procedures
Product Application References | Technical Support | Customer Service | How to Order
Contact Us 

Copyright © 2004 Cascade BioScience, Inc. All rights reserved.

Description Catalog # Vial Size Price (USD)
Anti-Murine CD36 (clone 63) ABM-5525 100 ug $295
Research Applications
Antibody Characteristics
1:1000 dilution
Flow Cytometry
1:1000 dilution
1:1000 dilution
Funtional Studies
InfoSheet PDF
About CD36
rat, mouse; others likely
full-length adenovirus vector injected into CD36 null mice
Host/Ig Type:
mouse monoclonal IgA
protein L chromatography
Quality Control:
Flow Cytometry using elicited mouse peritoneal macrophages incubated with CD36 antibody
1 year
Murine insulin treated or untreated adipocytes fixed with acetone were incubated with murine anti-mouse CD36 antibody (1:100 dilution of supernatent), followed by FITC-conjugated IgA-specific secondary antibody. Confocal microscopy revealed prominent membrane staining (left panels). Phase contrast images are shown in the right panels.
F l ow Cytometry:
Elicited mouse peritoneal macrophages were incubated with murine anti-mouse CD36 antibody (1:100 dilution of supernatent) or an isotype control (IgA), followed by FITC -conjugated IgA specific secondary antibody, and then analyzed by flow cytometry. The shaded peak shows high level expression of CD36.
Application References
Febbraio, M., Hajjar, D.P., and R.L. Silverstein. (2001) "CD36: A Class B Scavenger Receptor involved in angiogenesis, atherosclerosis, inflammation and lipid metabolism." J Clin Invest. 2001 Sep;108(6):785-91

Dawson, D.W., Pearce, S.F.A., Zhong R., Silverstein, R.L., Frazier,W.A., and N.P. Bouck. (1997) "CD36 Mediates the Inhibitory Effects of Thrombospondin-1 on Endothelial Cells." J. Cell Biology 138: 707-717

Febbraio, M., Abumrad, N.A., Hajjar, D.P., Sharma, K., Cheng W., Pearce, S.F.A., and R.L. Silverstein. (1999) "A null mutation in murine CD36 reveals an inportant role in fatty acid and lipoprotein metabolism." J. Biol. Chem 274:19055-19062

Silverstein, R. L. and M. Febbraio. (2000) "CD36 and Atherosclerosis. Current Opinions in Lipidology." 11:483-491

Functional Studies:
Antibody blocked uptake of oxidized LDL by murine macrophages and prevented foam cell formation in vitro. Antibody blocked oxidized LDLdependent activation of macrophage JNK kinase.
enlarge image
enlarge image

Chien-Ping Liang, Seongah Han, Haruka Okamoto, Ronald Carnemolla, Ira Tabas, Domenico Accili, and Alan R. Tall “Increased CD36 protein as a response to defective insulin signaling in macrophages” J Clin Invest. 2004 March 1; 113 (5): 764–773
full text

Lynn Corcoran,  David Vremec,  Maria Febbraio,  Tracey Baldwin and Emanuela Handman “Differential regulation of CD36 expression in antigen-presenting cells: Oct-2 dependence in B lymphocytes but not dendritic cells or macrophages” International Immunology, Vol. 14, No. 10, pp. 1099-1104, October 2002
full text

Kuniyasu A, Ohgami N, Hayashi S, Miyazaki A, Horiuchi S, Nakayama H.”CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes.” FEBS Lett. 2003 Feb 27;537(1-3):85-90.
Abstract 6 more...

General References